Preventive Effect of Cilostazol on Pneumonia in Patients with Acute Cerebral Infarction

The antiplatelet drug cilostazol decreases the risk of ischemic stroke recurrence in patients with chronic cerebral infarction. Additionally, cilostazol reduces the occurrence of pneumonia in these patients. The purpose of this study was to investigate whether cilostazol is effective for preventing pneumonia in patients with acute cerebral infarction.
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Source Type: research